Wall Street brokerages expect that Amdocs Limited (NASDAQ:DOX) will report $1.01 billion in sales for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for Amdocs’ earnings. Amdocs reported sales of $966.70 million during the same quarter last year, which indicates a positive year over year growth rate of 4.5%. The business is expected to announce its next earnings report on Wednesday, August 1st.
On average, analysts expect that Amdocs will report full year sales of $3.99 billion for the current fiscal year, with estimates ranging from $3.99 billion to $4.00 billion. For the next financial year, analysts forecast that the business will report sales of $4.15 billion per share, with estimates ranging from $4.13 billion to $4.21 billion. Zacks’ sales averages are an average based on a survey of research analysts that follow Amdocs.
Amdocs (NASDAQ:DOX) last released its quarterly earnings results on Thursday, May 10th. The technology company reported $0.95 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.95. Amdocs had a return on equity of 15.07% and a net margin of 11.36%. The business had revenue of $992.34 million during the quarter, compared to analyst estimates of $980.59 million. During the same quarter in the previous year, the company posted $0.94 earnings per share. Amdocs’s revenue for the quarter was up 2.7% on a year-over-year basis.
NASDAQ:DOX traded up $0.19 during mid-day trading on Friday, hitting $66.88. 553,160 shares of the company traded hands, compared to its average volume of 771,476. Amdocs has a one year low of $61.00 and a one year high of $71.72. The firm has a market capitalization of $9.56 billion, a PE ratio of 18.84, a P/E/G ratio of 2.24 and a beta of 0.55.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 20th. Stockholders of record on Friday, June 29th will be paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 1.50%. The ex-dividend date is Thursday, June 28th. Amdocs’s dividend payout ratio (DPR) is 28.17%.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Royal Bank of Canada lifted its position in shares of Amdocs by 23.9% in the first quarter. Royal Bank of Canada now owns 737,708 shares of the technology company’s stock worth $49,220,000 after buying an additional 142,300 shares in the last quarter. TLP Group LLC lifted its position in shares of Amdocs by 111.0% in the first quarter. TLP Group LLC now owns 6,808 shares of the technology company’s stock worth $454,000 after buying an additional 3,581 shares in the last quarter. Amundi Pioneer Asset Management Inc. lifted its position in shares of Amdocs by 90.8% in the first quarter. Amundi Pioneer Asset Management Inc. now owns 1,028,328 shares of the technology company’s stock worth $68,609,000 after buying an additional 489,297 shares in the last quarter. Cubist Systematic Strategies LLC lifted its position in shares of Amdocs by 83.0% in the first quarter. Cubist Systematic Strategies LLC now owns 17,130 shares of the technology company’s stock worth $1,143,000 after buying an additional 7,771 shares in the last quarter. Finally, Guggenheim Capital LLC lifted its position in shares of Amdocs by 391.9% in the first quarter. Guggenheim Capital LLC now owns 51,321 shares of the technology company’s stock worth $3,424,000 after buying an additional 40,887 shares in the last quarter. 92.35% of the stock is owned by hedge funds and other institutional investors.
Amdocs Limited, through its subsidiaries, provides software and services solutions to the communications, entertainment, pay TV, and media industry service providers worldwide. The company offers customer experience and monetization solutions that allow its customers to contextual and personalize interactions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.